FM
IOVA icon

Frazier Management’s Iovance Biotherapeutics IOVA Stock Holding History

Frazier Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,747,622
Closed -$33.4M – 14
2021
Q4 		$33.4M Sell
1,747,622
-926,677
-35% -$20.4M 2.57% 13
2021
Q3 		$65.9M Buy
2,674,299
+536,300
+25% +$12.6M 5.28% 4
2021
Q2 		$55.6M Buy
2,137,999
+825,000
+63% +$21.4M 5.13% 6
2021
Q1 		$41.6M Hold
1,312,999
– – 3.33% 8
2020
Q4 		$60.9M Hold
1,312,999
– – 4.69% 7
2020
Q3 		$43.2M Hold
1,312,999
– – 3.88% 6
2020
Q2 		$36M Sell
1,312,999
-437,666
-25% -$14.4M 3.16% 9
2020
Q1 		$52.4M Hold
1,750,665
– – 5.94% 4
2019
Q4 		$48.5M Hold
1,750,665
– – 8.13% 4
2019
Q3 		$31.9M Sell
1,750,665
-437,666
-20% -$9.68M 9.96% 3
2019
Q2 		$53.7M Hold
2,188,331
– – 13.75% 2
2019
Q1 		$20.8M Hold
2,188,331
– – 5.01% 7
2018
Q4 		$19.4M Hold
2,188,331
– – 5% 5
2018
Q3 		$24.6M Hold
2,188,331
– – 4.51% 6
2018
Q2 		$28M Hold
2,188,331
– – 5.8% 6
2018
Q1 		$37M Hold
2,188,331
– – 6.14% 4
2017
Q4 		$17.5M Hold
2,188,331
– – 2.84% 8
2017
Q3 		$17M Hold
2,188,331
– – 6.05% 6
2017
Q2 		$15.2M Hold
2,188,331
– – 7.8% 5
2017
Q1 		$16.3M Hold
2,188,331
– – 8.71% 4
2016
Q4 		$15.2M Buy
2,188,331
+101,050
+5% +$695K 19.14% 2
2016
Q3 		$17.2M Buy
2,087,281
+1,312,561
+169% +$11.1M 8.43% 4
2016
Q2 		$6.28M Buy
+774,720
New +$4.87M 5.01% 6

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Frazier Management's IOVA Position: Q1 2022 in Review

Frazier Management sold out of Iovance Biotherapeutics (IOVA) in Q1 2022, closing a stake of 1,747,622 shares — an estimated $33.4M sold.

Frazier Management first reported a position in IOVA in Q2 2016 and held it in 23 quarters. The position peaked at $65.9M in Q3 2021. 249 funds tracked by Wall St. Rank hold IOVA as of Q1 2022.

  • Frazier Management reported no remaining Iovance Biotherapeutics position as of Q1 2022 after selling out during the quarter.
  • Frazier Management sold 1,747,622 Iovance Biotherapeutics shares in Q1 2022, an estimated $33.4M.
  • Frazier Management first reported a position in Iovance Biotherapeutics in Q2 2016 and held it in 23 quarters.
  • Frazier Management's Iovance Biotherapeutics position peaked at $65.9M in Q3 2021.
  • 249 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2022.

Based on Frazier Management's 13F filing for Q1 2022, filed 13 May 2022.